
Chinese General Practice ›› 2020, Vol. 23 ›› Issue (36): 4554-4561.DOI: 10.12114/j.issn.1007-9572.2020.00.503
• Monographic Research • Previous Articles Next Articles
Published:2020-12-20
Online:2020-12-20
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2020.00.503
| [1]郭立新.无症状高尿酸血症合并心血管疾病诊治建议中国专家共识解读[J].中国实用内科杂志,2011,31(4):271-273. GUO L X.Interpretation of the Chinese expert consensus recommendations for diagnosis and treatment of asymptomatic hyperuricemia complicated with cardiovascular diseases[J].Chinese Journal of Practical Internal Medicine,2011,31(4):271-273. [2]LIU R,HAN C,WU D,et al.Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014:a systematic review and meta-analysis[J].Biomed Res Int,2015,2015:762820.DOI:10.1155/2015/762820. [3]顾景范.《中国居民营养与慢性病状况报告(2015)》解读[J].营养学报,2016,38(6):525-529.DOI:10.3969/j.issn.0512-7955.2016.06.005. [4]李斌,岳妍,贾山移,等.2010—2014年重庆市渝中区教师人群血尿酸水平与血压的关系[J].中华高血压杂志,2017,25(5):473-476. [5]卢春晖.老年健康体检者血尿酸水平与血压及原发性高血压的关系[J].临床医学研究与实践,2018,3(26):99-100.DOI:10.19347/j.cnki.2096-1413.201826047. LU C H.Association between serum uric acid level and blood pressure and essential hypertension in elder health examiners[J].Clinical Research and Practice,2018,3(26):99-100.DOI:10.19347/j.cnki.2096-1413.201826047. [6]FOROUZANFAR M H,LIU P,ROTH G A,et al.Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg,1990-2015[J].JAMA,2017,317(2):165-182.DOI:10.1001/jama.2016.19043. [7]KANSUI,MATSUMURA K,MORINAGA Y,et al.Impact of serum uric acid on incident hypertension in a worksite population of Japanese men[J].J Hypertens,2018,36(7):1499-1505.DOI:10.1097/HJH.0000000000001743. [8]KUWABARA M,HISATOME I,NIWA K,et al.Uric acid is a strong risk marker for developing hypertension from prehypertension:a 5-year Japanese cohort study[J].Hypertension,2018,71(1):78-86.DOI:10.1161/HYPERTENSIONAHA.117.10370. [9]LIANG J,XUE Y,ZOU C Y,et al.Serum uric acid and prehypertension among Chinese adults[J].J Hypertens,2009,27(9):1761-1765.DOI:10.1097/HJH.0b013e32832e0b44. [10]BAO X D,WANG Q,CHEN G W,et al.Serum concentration of uric acid associated with prehypertension among Chinese population[J].Angiology,2014,65(9):800-805.DOI:10.1177/0003319713507628. [11]SHEN Y,CHANG C,ZHANG J R,et al.Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China:a cross-sectional study[J].Environ Health Prev Med,2017,22(1):19.DOI:10.1186/s12199-017-0634-7. [12]BORGI L,MCMULLAN C,WOHLHUETER A,et al.Effect of uric acid-lowering agents on endothelial function:a randomized,double-blind,placebo-controlled trial[J].Hypertension,2017,69(2):243-248.DOI:10.1161/HYPERTENSIONAHA.116.08488. [13]MCMULLAN C J,BORGI L,FISHER N,et al.Effect of uric acid lowering on renin-angiotensin-system activation and ambulatory BP:a randomized controlled trial[J].Clin J Am Soc Nephrol,2017,12(5):807-816.DOI:10.2215/CJN.10771016. [14]SEGAL M S,SRINIVAS T R,MOHANDAS R,et al.The effect of the addition of allopurinol on blood pressure control in African Americans treated with a thiazide-like diuretic[J].J Am Soc Hypertens,2015,9(8):610-619.e1.DOI:10.1016/j.jash.2015.05.009. [15]K?TTGEN A,ALBRECHT E,TEUMER A,et al.Genome wide association analysis identity 18 new loci associated with serum urate concentrations[J].Nat Genet,2013,45(2):145-154. [16]YANG Q,K?TTGEN A,DEHGHAN A,et al.Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors[J].Circ Cardiovasc Genet,2010,3(6):523-530.DOI:10.1161/CIRCGENETICS.109.934455. [17]郭丽.凉山地区健康体检青年人群高血压患病情况及相关因素分析[J].中国全科医学,2017,20(S2):263-264. GUO L.Analysis on the condition of high blood pressure and related factors in the health examination of young people in Liangshan area[J].Chinese General Practice,2017,20(S2):263-264. [18]马晓菊,贾红,周艾婧,等.凉山地区HUA患病与尿酸转运蛋白相关基因单核苷酸多态性的关联性研究[J].四川大学学报(医学版),2019,50(1):93-95. MA X J,JIA H,ZHOU A J,et al.Association between HUA disease and si ngle nucleotide polymorphism of uric acid transporter-related gen es in Liangshan area[J].Journal of Sichuan University(Medical Science Edition),2019,50(1):93-95. [19]李爽境,黄闪闪,刘熹润,等.凉山州部分居民慢性病相关生活方式和行为习惯的调查[J].现代预防医学,2018,45(21):3933-3936,3941. LI S J,HUANG S S,LIU X R,et al.Chronic non-communicable diseases related to lifestyle and behaviour in part residents,Liangshan[J].Modern Preventive Medicine,2018,45(21):3933-3936,3941. [20]HUANG S S,LIU X R,LI H,et al.Sex difference in the association of serum uric acid with metabolic syndrome and its components:a cross-sectional study in a Chinese Yi population[J].Postgrad Med,2017,129(8):828-833.DOI:10.1080/00325481.2017.1372034. [21]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):前插1,701-743. Chinese Guidelines for the Management of Hypertension Writing Group.2010 Chinese guidelines for the management of hypertension[J].Chinese Journal of Hypertension,2011,19(8):front insert 1,701-743. [22]中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults.Chinese guidelines on prevention and treatment of dyslipidemia in adults[J].Chinese Journal of Cardiology,2007,35(5):390-419. [23]PARK J,KWOCK C K,YANG Y J.The effect of the sodium to potassium ratio on hypertension prevalence:a propensity score matching approach[J].Nutrients,2016,8(8):E482.DOI:10.3390/nu8080482. [24]ROSENBAUM P R,RUBIN D B.The central role of the propensity score in observational studies for causal effects[J].Biometrika,1983,70(1):41-55.DOI:10.1093/biomet/70.1.41. [25]HAUKOOS J S,LEWIS R J.The propensity score[J].JAMA,2015,314(15):1637-1638.DOI:10.1001/jama.2015.13480. [26]ROSENBAUM P R,RUBIN D B.Constructing a control group using multivariate matched sampling methods that incorporate the propensity score[J].Am Stat,1985,39(1):33-38.DOI:10.1080/00031305.1985.10479383. [27]CALIENDO M,KOPEINIG S.Some practical guidance for the implementation of propensity score matching[J].J Econ Surv,2008,22(1):31-72.DOI:10.1111/j.1467-6419.2007.00527.x. [28]EVANS S J.Stratification for spontaneous report databases[J].Drug Saf,2008,31(11):1049-1052.DOI:10.2165/00002018-200831110-00009. [29]YOKOKAWA H,FUKUDA H,SUZUKI A,et al.Association between serum uric acid levels/hyperuricemia and hypertension among 85,286 Japanese workers[J].J Clin Hypertens (Greenwich),2016,18(1):53-59.DOI:10.1111/jch.12627. [30]SUNG K C,BYRNE C D,RYU S,et al.Baseline and change in uric acid concentration over time are associated with incident hypertension in large Korean cohort[J].Am J Hypertens,2017,30(1):42-50.DOI:10.1093/ajh/hpw091. [31]王丹晨,李洪雷,侯立安,等.应用新、旧高血压诊断标准分析血清尿酸与高血压关系[J].标记免疫分析与临床,2018,25(9):1249-1252.DOI:10.11748/bjmy.issn.1006-1703.2018.09.001. WANG D C,LI H L,HOU L A,et al.An analysis of the association between serum uric acid and hypertension using new and old diagnostic criteria[J].Labeled Immunoassays and Clinical Medicine,2018,25(9):1249-1252.DOI:10.11748/bjmy.issn.1006-1703.2018.09.001. [32]LEIBA,VINKER S,DINOUR D,et al.Uric acid levels within the normal range predict increased risk of hypertension:a cohort study[J].J Am Soc Hypertens,2015,9(8):600-609.DOI:10.1016/j.jash.2015.05.010. [33]李丽娜,杨文浩,刘学军,等.尿酸累积暴露与高血压发病的关系[J].中国煤炭工业医学杂志,2018,21(2):177-182.DOI:10.11723/mtgyyx 1007-9564 201802016. LI L N,YANG W H,LIU X J,et al.Study on the association between cumulative serum uric acid and hypertension[J].Chinese Journal of Coal Industry Medicine,2018,21(2):177-182.DOI:10.11723/mtgyyx 1007-9564 201802016. [34]马孝湘,陈晓平,程幼夫,等.绝经后女性高血压患者血压水平与雌激素、糖化血红蛋白的相关性[J].中华高血压杂志,2014,22(10):974-976. [35]DE SOUZA A,FERNANDES V,FERRARI A J.Female gout:clinical and laboratory features[J].J Rheumatol,2005,32(11):2186-2188. [36]JIANG M L,GONG D D,FAN Y.Serum uric acid levels and risk of prehyperten sion:a meta-analysis[J].Clin Chem Lab Med,2017,55(3):314-321.DOI:10.1515/cclm-2016-0339. |
| [1] | ZHOU Xiaoya, WANG Weikai, LIU Qian, LI Jianhua, SUN Bo, WANG Yanxia. Study of the Interaction between Sleep Quality and Melatonin Receptor 1B Gene Polymorphism on Gestational Hypertension [J]. Chinese General Practice, 2026, 29(21): 2975-2981. |
| [2] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [3] | ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital [J]. Chinese General Practice, 2026, 29(19): 2614-2620. |
| [4] | MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei. Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2538-2545. |
| [5] | ZHANG Xinwen, WEI Guangcheng, ZHANG Xieyu, SHI Jinjie, LI Xiaoxu, MA Rui, YA Yulong, PENG Jiucheng, CAO Wei. The Causal Relationship between Sleep Patterns and Serum Uric Acid: a Bidirectional Mendelian Randomization Study [J]. Chinese General Practice, 2026, 29(17): 2354-2360. |
| [6] | XU Ping, MA Yan, HUANG Li, HE Meiliang, HOU Yunfeng, WANG Dewang, SUN Panpan, LIU Zheng, GUO Yanfang, XU Ying. Association between Weight-adjusted Waist Index and Comorbidity of Hypertension, Diabetes and Dyslipidemia in Community-dwelling Adults [J]. Chinese General Practice, 2026, 29(16): 2198-2204. |
| [7] | QIU Xinyu, ZHAO Qian, CHEN Yufei, JIAMULE· Maimaitiyiming, HAN Congcong, AIKEDAN· Aierken, LI Xiaomei, YANG Yining. Weight Status and Metabolic Characteristics on the Longitudinal Trajectory of Systolic Blood Pressure: a Cohort Study [J]. Chinese General Practice, 2026, 29(15): 2006-2013. |
| [8] | LIU Fan, CHEN Qiuyu, LI Jing. Development and Validation of a Nighttime Hypertension Screening Model for Subclinical High-risk Populations: a Single-center Cohort Study [J]. Chinese General Practice, 2026, 29(15): 1998-2005. |
| [9] | LIU Tianyuan, SANG Wanyue, PENG Jiping, CHENG Siyi, HUANG Yiyi, LI Ouwen, JIANG Hong, ZHOU Xiaoya. Correlation Analysis between Neurofilament Light Chain and the Risk of Left Ventricular Hypertrophy in Patients with Nocturnal Hypertension [J]. Chinese General Practice, 2026, 29(15): 2014-2021. |
| [10] | WANG Siman, ZHANG Mengchu, LI Wen, XU Ai, XU Jin, GUO Rui, YAN Haixia. Research on the Construction of a Risk Prediction Model for Primary Hypertension with Left Ventricular Hypertrophy Based on TCM Syndromes and Pulse Graph Parameters [J]. Chinese General Practice, 2026, 29(14): 1840-1848. |
| [11] | WU Chunxiang, TIAN Jie, GUO Yi, DENG Bo, YU Jie, CAI Ning, SHEN Li. Analysis of the 8-year Trajectories and Influencing Factors of Medical-help-seeking Behavior of Hypertensive Patients [J]. Chinese General Practice, 2026, 29(13): 1660-1665. |
| [12] | SONG Lu, WANG Liye, XIU Chunxia, FENG Baojing, FENG Liping, GAO Yansong, LI Meng, DAI Yan. The Correlation Study of Pulmonary Function and Blood Pressure Variability in Patients with Chronic Obstructive Pulmonary Disease and Hypertension [J]. Chinese General Practice, 2026, 29(10): 1311-1315. |
| [13] | JIAO Xitong, LIU Lu, GUO Jiayue, YOU Lili. Prospects for the Application of Digital Therapy Products for Hypertension at Home and Abroad and the Implications for China [J]. Chinese General Practice, 2026, 29(10): 1354-1360. |
| [14] | TANG Xinyi, HU Xinyu, LIU Shanshan, ZHANG Yimin. Research on the Impact of Establishing Health Records Based on Propensity Score Matching Method on the Medical Behavior of Elderly People [J]. Chinese General Practice, 2026, 29(07): 858-863. |
| [15] | ZHANG Qiuyu, HU Xiaoyong, TANG Rui, LI Hongjian. Correlation between Chinese Visceral Adiposity Index and Nocturnal Hypertension in Young and Middle-aged People [J]. Chinese General Practice, 2026, 29(07): 872-878. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||